Leptomeningeal metastases (LM) represent a critical and increasingly documented complication in patients with progressive solid organ and hematologic neoplasms, distinguished by cancer cell dissemination throughout the leptomeningeal tissues and cerebrospinal fluid (CSF) system. The treatment environment is experiencing unprecedented transformation as healthcare specialists, research...